{"id":25826,"date":"2021-05-13T20:59:40","date_gmt":"2021-05-14T00:59:40","guid":{"rendered":"http:\/\/cfif.org\/v\/freedom_line_blog\/?p=25826"},"modified":"2021-05-14T09:16:51","modified_gmt":"2021-05-14T13:16:51","slug":"image-of-the-day-private-sector-pharmaceutical-investment-propels-innovation","status":"publish","type":"post","link":"https:\/\/cfif.org\/v\/freedom_line_blog\/25826\/image-of-the-day-private-sector-pharmaceutical-investment-propels-innovation\/","title":{"rendered":"Image of the Day:  Private Sector Pharmaceutical Investment Propels Innovation"},"content":{"rendered":"<p>As we&#8217;ve <a href=\"https:\/\/cfif.org\/v\/freedom_line_blog\/25663\/image-of-the-day-private-rd-dwarfs-public-funding\/\">highlighted<\/a>, the dangerous effort to weaken critical patent protections for U.S. pharmaceutical innovators often minimizes the role of private investment and exaggerates the role of public funding.\u00a0 This offers a critical corrective at a moment when American drug and vaccine innovation is more important than ever:<\/p>\n<p><a href=\"https:\/\/catalyst.phrma.org\/hs-fs\/hubfs\/PhRMA_Catalyst_NIH_In-Blog_Graph%20(3).jpg?width=2400&amp;name=PhRMA_Catalyst_NIH_In-Blog_Graph%20(3).jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"\" src=\"https:\/\/catalyst.phrma.org\/hs-fs\/hubfs\/PhRMA_Catalyst_NIH_In-Blog_Graph%20(3).jpg?width=2400&amp;name=PhRMA_Catalyst_NIH_In-Blog_Graph%20(3).jpg\" alt=\"The Critical Role of Private Pharmaceutical Investment\" width=\"530\" height=\"319\" \/><\/a> The Critical Role of Private Pharmaceutical Investment<\/p>\n","protected":false},"excerpt":{"rendered":"<p>As we&#8217;ve highlighted, the dangerous effort to weaken critical patent protections for U.S. pharmaceutical innovators often minimizes the role of private investment and exaggerates the role of public funding.\u00a0 This offers a critical corrective at a moment when American drug and vaccine innovation is more important than ever:<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1251,1684,2871,1958,2872,5057,4805],"class_list":["post-25826","post","type-post","status-publish","format-standard","hentry","category-posts","tag-drugs","tag-innovation","tag-intellectual-property","tag-investment","tag-ip","tag-patents","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/cfif.org\/v\/freedom_line_blog\/wp-json\/wp\/v2\/posts\/25826","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cfif.org\/v\/freedom_line_blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cfif.org\/v\/freedom_line_blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cfif.org\/v\/freedom_line_blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/cfif.org\/v\/freedom_line_blog\/wp-json\/wp\/v2\/comments?post=25826"}],"version-history":[{"count":3,"href":"https:\/\/cfif.org\/v\/freedom_line_blog\/wp-json\/wp\/v2\/posts\/25826\/revisions"}],"predecessor-version":[{"id":25830,"href":"https:\/\/cfif.org\/v\/freedom_line_blog\/wp-json\/wp\/v2\/posts\/25826\/revisions\/25830"}],"wp:attachment":[{"href":"https:\/\/cfif.org\/v\/freedom_line_blog\/wp-json\/wp\/v2\/media?parent=25826"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cfif.org\/v\/freedom_line_blog\/wp-json\/wp\/v2\/categories?post=25826"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cfif.org\/v\/freedom_line_blog\/wp-json\/wp\/v2\/tags?post=25826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}